Clinical Trials 2 분 읽기

Randomized Controlled Trials

Randomized controlled trials are the gold standard for establishing causal relationships between drug treatments and clinical outcomes.


## What Is a Randomized Controlled Trial?

A randomized controlled trial (RCT) is a study design in which participants are randomly assigned to receive either the experimental treatment or a control (placebo, active comparator, or standard of care). Randomization eliminates selection bias and ensures that known and unknown confounding variables are evenly distributed between groups, allowing researchers to attribute outcome differences to the treatment itself.

## Why Randomization Matters

Without randomization, treatment groups may differ systematically. Sicker patients might receive the experimental drug while healthier patients get the control, or vice versa. Randomization ensures that any baseline differences between groups are due to chance alone, not systematic bias. This is the fundamental reason why RCTs provide the strongest evidence for causal inference.

## Randomization Methods

### Simple Randomization

Each participant has an equal probability (typically 50/50) of being assigned to either group, like flipping a coin. Simple randomization works well for large trials but can produce imbalanced groups in small studies.

### Block Randomization

Participants are randomized within blocks of fixed size (e.g., blocks of 4 or 6) to ensure equal numbers in each group throughout enrollment. This prevents the temporal imbalances that simple randomization can create.

### Stratified Randomization

Randomization occurs within predefined strata based on prognostic variables (e.g., disease severity, age group, or study site). This guarantees balance on important baseline characteristics, particularly in smaller trials where chance imbalances are more likely.

## Control Group Selection

- **Placebo control**: Used when no proven treatment exists or when add-on therapy is being tested. Ethically requires clinical equipoise.
- **Active control**: Compares the new drug to current standard of care. Required when withholding treatment would be harmful.
- **Dose-response control**: Different dose levels of the same drug serve as internal controls.

## Intention-to-Treat Analysis

RCTs analyze results based on the group to which participants were originally randomized, regardless of whether they completed treatment or crossed over. This intention-to-treat (ITT) principle preserves the benefits of randomization and reflects real-world treatment effects where non-adherence occurs.

## Limitations

RCTs have strict eligibility criteria that may exclude patients commonly seen in clinical practice. Results from a controlled trial population may not fully generalize to broader real-world populations with multiple comorbidities and concomitant medications.

## Key Takeaways

- RCTs are the gold standard for establishing treatment efficacy
- Randomization controls for both known and unknown confounders
- Block and stratified randomization prevent imbalances in smaller trials
- Intention-to-treat analysis preserves the integrity of randomization
- Control group selection depends on ethical considerations and existing treatments

Related Guides